Literature DB >> 7972251

Receptor-mediated pharmacodynamics of corticosteroids.

W J Jusko1.   

Abstract

Major conclusions from these studies are that receptor occupancy usually directly governs biologic responses to corticosteroids and that the slow onset of effects is caused not by pharmacokinetic factors but by the time needed for mRNA and protein synthesis. The slow dissipation of steroid effects is governed by steroid elimination (time to decline below KD values), the KD for receptor binding, and the time required for mRNA and the TAT enzyme to readjust to baseline conditions. These studies provide insight concerning the integrated role of drug, receptors, and biologic response mediators in determining the role of dose, time, type of corticosteroid, and drug-disease interactions in governing the pharmacodynamics of these agents. The models are of more general value in pharmacology as well, for these cascade models should be relevant to the quantitation of any type of gene-mediated drug effect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972251

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  7 in total

Review 1.  Application of quantitative pharmacology in development of therapeutic monoclonal antibodies.

Authors:  Mohammad Tabrizi; Cherryl Funelas; Hamza Suria
Journal:  AAPS J       Date:  2010-07-24       Impact factor: 4.009

2.  A stochastic version of corticosteriod pharmacogenomic model.

Authors:  Xiaohong Qi
Journal:  AAPS J       Date:  2005-06-23       Impact factor: 4.009

3.  NETWORKS, BIOLOGY AND SYSTEMS ENGINEERING: A CASE STUDY IN INFLAMMATION.

Authors:  P T Foteinou; E Yang; I P Androulakis
Journal:  Comput Chem Eng       Date:  2009-12-10       Impact factor: 3.845

4.  Modeling autonomic regulation of cardiac function and heart rate variability in human endotoxemia.

Authors:  Jeremy D Scheff; Panteleimon D Mavroudis; Steven E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  Physiol Genomics       Date:  2011-06-14       Impact factor: 3.107

5.  Pharmacodynamics of glucose regulation by methylprednisolone. I. Adrenalectomized rats.

Authors:  Jin Y Jin; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2009-01       Impact factor: 1.627

6.  Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.

Authors:  Rohini Ramakrishnan; Debra C DuBois; Richard R Almon; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

7.  In silico simulation of corticosteroids effect on an NFkB- dependent physicochemical model of systemic inflammation.

Authors:  Panagiota T Foteinou; Steve E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.